Human infections caused by Brevibacterium casei, formerly CDC groups B-1 and B-3
| Autor: | D G Hollis, Eva Gruner, C W Moss, J M Brown, D J Brenner, R E Weaver, M Daneshvar, R S Weyant, A G Steigerwalt |
|---|---|
| Rok vydání: | 1994 |
| Předmět: |
DNA
Bacterial Microbiology (medical) Brevibacteriaceae Carbohydrates Bacteremia Meningitis Bacterial Microbiology Bacterial genetics Species Specificity Cell Wall Genotype Brevibacterium Humans Brevibacterium epidermidis Brevibacterium casei chemistry.chemical_classification biology Nucleic Acid Hybridization food and beverages biology.organism_classification Amino acid Pleural Effusion chemistry Actinomycetales Infections Bacteria Research Article |
| Zdroj: | Journal of Clinical Microbiology. 32:1511-1518 |
| ISSN: | 1098-660X 0095-1137 |
| DOI: | 10.1128/jcm.32.6.1511-1518.1994 |
| Popis: | Forty-one clinical strains of CDC coryneform groups B-1 and B-3 were compared biochemically, by analysis of cell wall sugars, amino acids, and cellular fatty acids, and by DNA relatedness to the type strains of Brevibacterium casei, Brevibacterium epidermidis, and Brevibacterium linens. Twenty-two strains were shown to be B. casei, while five other strains formed a phenotypically inseparable genomospecies in the same genus. The remaining isolates were genetically heterogeneous, and most are probably members of the genus Brevibacterium. They were not further identified, but they were biochemically distinguishable from B. casei. Eleven of the clinical strains of B. casei were isolated from blood, and two each were isolated from cerebrospinal fluid and from pleural fluid. At least five isolates were from multiple blood or cerebrospinal fluid cultures. To our knowledge, these strains are the first described clinical isolates identified as B. casei, which was previously considered to be a nonpathogenic species. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|